JP2004500321A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004500321A5 JP2004500321A5 JP2000606604A JP2000606604A JP2004500321A5 JP 2004500321 A5 JP2004500321 A5 JP 2004500321A5 JP 2000606604 A JP2000606604 A JP 2000606604A JP 2000606604 A JP2000606604 A JP 2000606604A JP 2004500321 A5 JP2004500321 A5 JP 2004500321A5
- Authority
- JP
- Japan
- Prior art keywords
- reversible
- dose
- washing
- application
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010047139 Vasoconstriction Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000025033 vasoconstriction Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12516699P | 1999-03-19 | 1999-03-19 | |
| PCT/CA2000/000294 WO2000056743A1 (en) | 1999-03-19 | 2000-03-17 | Pharmaceutical compositions comprising metal complexes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004500321A JP2004500321A (ja) | 2004-01-08 |
| JP2004500321A5 true JP2004500321A5 (enExample) | 2004-12-24 |
Family
ID=22418482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000606604A Withdrawn JP2004500321A (ja) | 1999-03-19 | 2000-03-17 | 金属錯体を含む薬学的組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20020049190A1 (enExample) |
| EP (1) | EP1163247A1 (enExample) |
| JP (1) | JP2004500321A (enExample) |
| KR (1) | KR20010112343A (enExample) |
| CN (1) | CN1391577A (enExample) |
| AU (1) | AU3268500A (enExample) |
| BR (1) | BR0011678A (enExample) |
| CA (1) | CA2367282A1 (enExample) |
| CZ (1) | CZ20013307A3 (enExample) |
| HU (1) | HUP0400457A2 (enExample) |
| IL (1) | IL145290A0 (enExample) |
| MX (1) | MXPA01009410A (enExample) |
| NO (1) | NO20014526L (enExample) |
| PL (1) | PL356683A1 (enExample) |
| WO (1) | WO2000056743A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ303156B6 (cs) | 1999-04-13 | 2012-05-09 | Anormed Inc. | Komplex cisplatiny a zpusob jeho prípravy |
| JP4227701B2 (ja) * | 1999-05-25 | 2009-02-18 | 中部キレスト株式会社 | ジエチレントリアミン五酢酸ルテニウム二アンモニウム塩またはその水和物およびその製法 |
| US6489638B2 (en) * | 2000-06-23 | 2002-12-03 | Semiconductor Energy Laboratory Co., Ltd. | Light emitting device |
| US6894049B1 (en) | 2000-10-04 | 2005-05-17 | Anormed, Inc. | Platinum complexes as antitumor agents |
| US20020072512A1 (en) * | 2000-12-08 | 2002-06-13 | Metaphore Pharmaceuticals, Inc | Method of preventing and treating HIV-mediated central nervous system damage |
| GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
| EP2319518A1 (en) | 2002-02-04 | 2011-05-11 | ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. | Use of CO-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
| GB2395431A (en) * | 2002-11-20 | 2004-05-26 | Northwick Park Inst For Medica | Combination of a metal carbonyl compound and a guanylate cyclase stimulant or stabilizer for the therapeutic delivery of carbon monoxide |
| GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
| ES2390457T3 (es) * | 2003-08-04 | 2012-11-13 | Johnson & Johnson Consumer Companies, Inc. | Métodos para el tratamiento de enfermedades dermatológicas |
| EP1712547B1 (en) | 2004-02-05 | 2011-12-14 | Kyorin Pharmaceutical Co., Ltd. | Bicycloester derivative |
| FR2873037B1 (fr) * | 2004-07-13 | 2008-04-11 | Univ Pasteur | Methodes et compositions pour le traitement de cancers |
| WO2007072018A2 (en) * | 2005-12-21 | 2007-06-28 | Oxford Biosensors Ltd | Redox mediators |
| GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
| CA2645154C (en) | 2006-03-08 | 2011-11-29 | Kyorin Pharmaceutical Co., Ltd. | Method for producing aminoacetylpyrrolidinecarbonitrile derivative and production intermediate thereof |
| EP2032701B1 (en) * | 2006-06-23 | 2013-11-27 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptides involved in cancer |
| WO2008038305A2 (en) * | 2006-09-26 | 2008-04-03 | Jegannathan Srinivas | Therapeutical formulation comprising a thiazolidinedione and a nitric oxide scavenger. |
| JPWO2008114857A1 (ja) | 2007-03-22 | 2010-07-08 | 杏林製薬株式会社 | アミノアセチルピロリジンカルボニトリル誘導体の製造方法 |
| NZ592432A (en) | 2008-11-03 | 2013-01-25 | Alethia Biotherapeutics Inc | Antibodies that specifically block the biological activity of a tumor antigen Kidney associated antigen 1 (KAAG1) |
| DE102010014412A1 (de) | 2010-04-08 | 2012-04-19 | Friedrich-Schiller-Universität Jena | Verwendung von zweikernigen Eisenkomplexen mit schwefelhaltigen Liganden als pharmakologische Wirkstoffe |
| DE102010014411A1 (de) | 2010-04-08 | 2011-10-13 | Friedrich-Schiller-Universität Jena | Kohlenmonoxid und Eisen freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung |
| PT3173427T (pt) | 2011-03-31 | 2019-09-17 | Adc Therapeutics Sa | Anticorpos contra antigénio associado ao rim 1 e fragmentos de ligação a antigénio dos mesmos |
| JP5978291B2 (ja) | 2011-04-19 | 2016-08-24 | アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． | 一酸化炭素放出分子およびその使用 |
| JP6134710B2 (ja) | 2011-07-21 | 2017-05-24 | アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． | 一酸化ルテニウム放出分子およびその使用 |
| PT2802351T (pt) | 2012-01-09 | 2019-06-27 | Adc Therapeutics Sa | Agentes para o tratamento de cancro da mama triplo negativo |
| DE102012004132A1 (de) | 2012-02-29 | 2013-08-29 | Friedrich-Schiller-Universität Jena | Kohlenstoffmonoxid freisetzende Materialien und deren Verwendung |
| DE102014008537A1 (de) | 2014-06-04 | 2015-12-17 | Friedrich-Schiller-Universität Jena | Wasserlösliche manganbasierte Kohlenstoffmonoxid freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung |
| EP3212610B1 (en) * | 2014-10-30 | 2020-10-28 | Katholieke Universiteit Leuven | Methods for low temperature fluorine-18 radiolabeling of biomolecules |
| CN113429456B (zh) * | 2021-06-11 | 2022-05-31 | 首都医科大学 | 多肽衍生物钌类络合物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5112974A (en) * | 1985-01-18 | 1992-05-12 | The Trustees Of Columbia University In The City Of New York | Mixed ligand complexes and uses thereof as binding agents to DNA |
| US4721669A (en) * | 1985-01-18 | 1988-01-26 | The Trustees Of Columbia University In The City Of New York | Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents |
| GB9317686D0 (en) * | 1993-08-25 | 1993-10-13 | Johnson Matthey Plc | Pharmaceutical compositions |
| SE9703396D0 (sv) * | 1997-09-19 | 1997-09-19 | Lincoln | Binuclear complex |
-
2000
- 2000-03-17 WO PCT/CA2000/000294 patent/WO2000056743A1/en not_active Ceased
- 2000-03-17 EP EP00910468A patent/EP1163247A1/en not_active Withdrawn
- 2000-03-17 HU HU0400457A patent/HUP0400457A2/hu unknown
- 2000-03-17 KR KR1020017011819A patent/KR20010112343A/ko not_active Withdrawn
- 2000-03-17 PL PL00356683A patent/PL356683A1/xx not_active Application Discontinuation
- 2000-03-17 US US09/527,450 patent/US20020049190A1/en not_active Abandoned
- 2000-03-17 BR BR0011678-5A patent/BR0011678A/pt not_active Application Discontinuation
- 2000-03-17 IL IL14529000A patent/IL145290A0/xx unknown
- 2000-03-17 AU AU32685/00A patent/AU3268500A/en not_active Abandoned
- 2000-03-17 CA CA002367282A patent/CA2367282A1/en not_active Abandoned
- 2000-03-17 MX MXPA01009410A patent/MXPA01009410A/es unknown
- 2000-03-17 JP JP2000606604A patent/JP2004500321A/ja not_active Withdrawn
- 2000-03-17 CZ CZ20013307A patent/CZ20013307A3/cs unknown
- 2000-03-17 CN CN00806748A patent/CN1391577A/zh active Pending
-
2001
- 2001-09-18 NO NO20014526A patent/NO20014526L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004500321A5 (enExample) | ||
| EE200300236A (et) | 1,2-difenüülasetidinoonid, nende kasutamine, ravim ja selle valmistamismeetod | |
| JP2004502858A5 (enExample) | ||
| CY2012032I2 (el) | Ενωσεις 1,2-διυδροπυριδινης, διεργασια για την παρασκευη των ιδιων και χρηση εξ αυτων | |
| DE50313653D1 (de) | Wasserlösliche eisen-kohlenhydrat-komplexe, deren herstellung und diese enthaltende arzneimittel | |
| EE200100413A (et) | Sünteetilised pindaktiivsed peptiidid ja nende kasutamine sünteetilise surfaktandi valmistamiseks | |
| NO20030929D0 (no) | Guanidinobenzamider som MC4-R agonister | |
| JP2002542199A5 (enExample) | ||
| EE05210B1 (et) | Suhkurt?vevastane preparaat ja selle kasutamine meditsiinis | |
| JP2006507281A5 (enExample) | ||
| EE200300171A (et) | Kristalliline monohüdraat, meetodid selle valmistamiseks ja selle kasutamine farmatseutilise kompositsiooni valmistamiseks | |
| DE60119679D1 (de) | Radlagervorrichtung und deren Herstellungsvorrichtung | |
| JP2003520017A5 (enExample) | ||
| DE60023103D1 (de) | Lüfter und dessen Herstellungverfahren | |
| DE60131663D1 (de) | Acylacetonitrile, deren herstellung und diese enthaltende miticide | |
| JP2001076484A5 (enExample) | ||
| DE60014694D1 (de) | Poröser silikatischer film mit niedriger durchlässigkeit, halbleiterelement mit solchem film, und beschichtungszusammensetzung den film bildend | |
| JP2003515534A5 (enExample) | ||
| DE60200719D1 (de) | Filmbildende Zusammensetzung, poröser Film und deren Herstellung | |
| NO20024810L (no) | Dermatologisk preparat samt anvendelse derav | |
| NL1013684A1 (nl) | Verknopingsmiddel voor fotolaklaag, en fotolaklaagsamenstelling welke dezelfde omvat. | |
| JPH11148936A5 (enExample) | ||
| DE60144265D1 (de) | Halbleiterbauelement und dessen herstelllung | |
| BR0012184B1 (pt) | compostos derivados de indol, formulação farmacêutica, e, composição e uso dos compostos na fabricação de medicamentos | |
| JP2007509878A5 (enExample) |